CityMedic, a medical devices company has obtained an approval from the Medical Devices Authority (MDA) for the launch of the Gmate Covid Saliva Home Test Kit from Korea. The company will start planning the commercialisation of the kits while waiting MDA to finalise the guidelines for self-kit importers. The test kit is expected to be available at all pharmacies nationwide starting on 19 July 2021.
The test kit recently passed the evaluation from the Institute of Medical Research (IMR) with an impressive 91% sensitivity and 100% specificity. The IMR has also conducted a survey on the product’s ease of use and 99% of the respondent said that it is easy to use, the instructions are easy to understand, and the interpretation of the test results is very straight forward.
Gmate Covid Saliva Home Test Kit is manufactured by Philosys Ltd, a public listed medical devices company in South Korea. Philosys Ltd has appointed CityMedic as its exclusive distributor for the Malaysian and Singaporean market.
For more information about CityMedic, visit citymedic2u.com.